← FDA Warning Letters

Pinnacle Transplant Technologies, LLC

FDA Warning Letter · 2024-10-22 · Center for Biologics Evaluation and Research (CBER)

Letter

Company
Pinnacle Transplant Technologies, LLC
Posted Date
2024-10-22
Letter Issue Date
2024-10-01
Issuing Office
Center for Biologics Evaluation and Research (CBER)

Subject

Deviations/CFR/Regulations for Human Cells, Tissues & Cellular Products (HCT/Ps)

Source

Authoritative
FDA Warning Letters
Machine
JSON-LD · Markdown